arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

ELUTIA INC.

ELUT
$0.87 ▼ -0.01 (-1.56%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
29 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
42
Health
Weak
Neutral
auto_awesome

Analytical Summary

ELUTIA INC. demonstrates solid fundamentals with strength in Return on Common Equity (%). However, watch Operating Margin (%) which shows concerning trends. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $37.4M
Dividend Yield
Revenue Growth -48.4%
Op. Margin -203.9%
ROIC -28.4%
FCF / Share $-0.19
Trailing P/E
Price / Book 1.7x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 5, 2026.

29-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.11M
↓ -48.4%
Net Income Profit after all expenses
$-7.47M
↓ -89.9%
Operating Margin Operating profit as % of sales
-203.9%
↓ -30.1% 0th
FCF / Share Free cash flow per share
$-0.19
↑ +18.7%
Long-Term Debt Long-term obligations
$26.10M
↑ +3.9%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability
0
Returns
100
Financial Health
39
Cash Quality
11

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 29 quarters